Log in

Udg Healthcare Share Forecast, Price & News

GBX 767.50
+28.50 (+3.86 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: GBX 767.50
50-Day Range
MA: GBX 726.79
52-Week Range
Now: GBX 767.50
Volume463,594 shs
Average Volume583,629 shs
Market Capitalization£1.93 billion
P/E Ratio21.50
Dividend Yield1.77%
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; and serialization solutions. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.
Read More
Udg Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.53 out of 5 stars

Industry, Sector and Symbol

Industry Medical Distribution



Sales & Book Value

Annual Sales£1.34 billion
Cash FlowGBX 66.24 per share
Book ValueGBX 377.60 per share



Market Cap£1.93 billion
Next Earnings Date11/24/2020 (Estimated)
OptionableNot Optionable
GBX 767.50
+28.50 (+3.86 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive UDG News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Udg Healthcare (LON:UDG) Frequently Asked Questions

How has Udg Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Udg Healthcare's stock was trading at GBX 628.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, UDG shares have increased by 22.1% and is now trading at GBX 767.50.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Udg Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Udg Healthcare in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Udg Healthcare

When is Udg Healthcare's next earnings date?

Udg Healthcare is scheduled to release its next quarterly earnings announcement on Tuesday, November 24th 2020.
View our earnings forecast for Udg Healthcare

How often does Udg Healthcare pay dividends? What is the dividend yield for Udg Healthcare?

Udg Healthcare announced a dividend on Wednesday, August 5th. Shareholders of record on Thursday, August 20th will be paid a dividend of GBX 0.04 per share on Tuesday, September 15th. This represents a dividend yield of 0.48%. The ex-dividend date of this dividend is Thursday, August 20th. The official announcement can be accessed at this link.
View Udg Healthcare's dividend history

What price target have analysts set for UDG?

7 equities research analysts have issued twelve-month price objectives for Udg Healthcare's shares. Their forecasts range from GBX 735 to GBX 1,050. On average, they anticipate Udg Healthcare's stock price to reach GBX 874.29 in the next year. This suggests a possible upside of 13.9% from the stock's current price.
View analysts' price targets for Udg Healthcare

Who are some of Udg Healthcare's key competitors?

What other stocks do shareholders of Udg Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Udg Healthcare investors own include Carillion (CLLN), NBT Bancorp (NBTB), CRH (CRH), Standard Life Aberdeen (SL), BT Group - CLASS A (BT.A), Carclo (CAR), CBS (CBS), Greencore Group (GNC), Allergan (AGN) and Aviva (AV).

Who are Udg Healthcare's key executives?

Udg Healthcare's management team includes the following people:
  • Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 56)
  • Mr. Nigel Clerkin, CFO & Exec. Director (Age 45)
  • Keith Byrne, Head of Investor Relations, Strategy & Corp. Communications
  • Eleanor Garvey, Group Head of Quality & Compliance
  • Mr. Damien Moynagh, Gen. Counsel & Company Sec.

What is Udg Healthcare's stock symbol?

Udg Healthcare trades on the London Stock Exchange (LON) under the ticker symbol "UDG."

How do I buy shares of Udg Healthcare?

Shares of UDG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Udg Healthcare's stock price today?

One share of UDG stock can currently be purchased for approximately GBX 767.50.

How big of a company is Udg Healthcare?

Udg Healthcare has a market capitalization of £1.93 billion and generates £1.34 billion in revenue each year. Udg Healthcare employs 8,700 workers across the globe.

What is Udg Healthcare's official website?

The official website for Udg Healthcare is www.udghealthcare.com.

How can I contact Udg Healthcare?

Udg Healthcare's mailing address is River Walk 20, DUBLIN,, Ireland. The company can be reached via phone at +353-1-4689000.

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.